Vaxinia has been shown to shrink cancer tumors in animals, but its real test starts now.
First Patient Dosed With Experimental Cancer-Killing Virus in New Trial,Vaxinia has been shown to shrink cancer tumors in animals, but its real test starts now.
Cancer patients seek damages from Fukushima nuclear plant
A Tokyo court has begun hearings in a lawsuit seeking nearly $5 million in damages for six people who were children in Fukushima at the time of its 2011 nuclear power plant disaster and later developed thyroid cancer
Alarming rise found in esophageal cancer and Barrett’s esophagus in middle-aged adults
Adults aged 45 to 64 experienced a nearly doubled rate of esophageal cancer and a 50 percent increase in the precancerous condition Barrett's esophagus between 2012 and 2019, according to a database analysis of roughly five million patients to be presented at Digestive Disease Week 2022.
Gallstone disease shown to be strong predictor of pancreatic cancer
Patients with pancreatic ductal adenocarcinoma (PDAC) were six times more likely to have had gallstone disease within the year prior to diagnosis than non-cancer patients, suggesting gallstones could be a warning sign for this aggressive and deadly cancer, according to research to be presented at Digestive Disease Week (DDW) 2022. PDAC is the most common pancreatic cancer, accounting for more than 90% of cases, and it is often fatal because it tends to be diagnosed in late stages.
Precision oncology helps prostate cancer patients
Researchers at the University of Bern and University Hospital Bern have achieved a breakthrough in a particularly aggressive form of prostate cancer. In tissue samples from advanced brain metastases, they were able to establish the genetic profile of the cancer cells. These findings show for the first time that affected patients could benefit from target treatment, from which they have so far not been eligible.
Precision oncology helps prostate cancer patients
Researchers at the University of Bern and University Hospital Bern have achieved a breakthrough in a particularly aggressive form of prostate cancer. In tissue samples from advanced brain metastases, they were able to establish the genetic profile of the cancer cells. These findings show for the first time that affected patients could benefit from target treatment, from which they have so far not been eligible.
First mutation-targeted bladder cancer drug may be under-used
The first bladder cancer drug targeting a cancer-driving gene mutation has been used relatively little despite its clear efficacy in a clinical trial, suggests a study from researchers at the Perelman School of Medicine at the University of Pennsylvania.
Arthritis drug used to limit antibiotics in blood cancer patients
Researchers from the University of Adelaide and the Radboud University Medical Centre in the Netherlands have repurposed an arthritis drug to restrict the use of antibiotics in the treatment of side effects caused by blood cancer, including leukemia, lymphoma and myeloma.
Arthritis drug used to limit antibiotics in blood cancer patients
Researchers from the University of Adelaide and the Radboud University Medical Centre in the Netherlands have repurposed an arthritis drug to restrict the use of antibiotics in the treatment of side effects caused by blood cancer, including leukemia, lymphoma and myeloma.
Digital breast tomosynthesis tool can help predict breast cancer
An image-based risk prediction model using digital breast tomosynthesis (DBT) can predict the risk for breast cancer after a negative screening exam, according to a study published in the May 11 issue of Science Translational Medicine.
Delays in surgery for advanced esophageal cancer result in significantly worse survival than early surgery
Delays in surgery for esophageal cancer did not appear to have much impact on patients' relative survival for early-stage cancer compared with patients who had surgery early, but they did reduce the relative survival rate by almost half for patients with more advanced disease, according to an analysis of the National Cancer Database (NCDB).
First mutation-targeted bladder cancer drug may be under-used
The first bladder cancer drug targeting a cancer-driving gene mutation has been used relatively little despite its clear efficacy in a clinical trial, suggests a study from researchers at the Perelman School of Medicine at the University of Pennsylvania.
Digital breast tomosynthesis tool can help predict breast cancer
An image-based risk prediction model using digital breast tomosynthesis (DBT) can predict the risk for breast cancer after a negative screening exam, according to a study published in the May 11 issue of Science Translational Medicine.
Nebraska-led project examines milk as possible cancer fighter
In health care, perhaps no word sends a more chilling message than "cancer." Brain tumors, for example, prove especially resistant to current treatments. Only 5% of patients with that condition survive more than three years and the median survival time is 10 to 14 months.
New research encourages harnessing health technology to help cancer patients quit smoking
New research in the May 2022 issue of JNCCN—Journal of the National Comprehensive Cancer Network finds the inclusion of the smoking cessation tool Electronic Health Record-Enabled Evidence-Based Smoking Cessation Treatment (ELEVATE, from Epic) into electronic health records (EHRs) can increase self-reported patient quit rates by more than 5 percentage points. The study, from researchers at Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine—an NCCN Member Institution—was part of the National Cancer Institute (NCI) Cancer Moonshot program through the Cancer Center Cessation Initiative.
Study modeling tumor evolution reveals a vulnerability for cancer prevention and therapy
Though the mutations accumulated by cancer cells occur more or less randomly, certain regions of genes essential to cancer growth appear to be more frequently mutated than others in established tumors. Now, a study led by researchers at the Ludwig Center at Memorial Sloan Kettering (MSK), MSK, Weill Cornell Medical College in New York and the Icahn School of Medicine at Mount Sinai has modeled and experimentally verified the interplay between the selection of mutations in such genes and their tendency to invite an immune attack on tumor cells. Its findings, reported in the current issue of Nature, reveal a central tradeoff that guides tumor evolution and that might be exploited for both cancer prevention and therapy.
Study modeling tumor evolution reveals a vulnerability for cancer prevention and therapy
Though the mutations accumulated by cancer cells occur more or less randomly, certain regions of genes essential to cancer growth appear to be more frequently mutated than others in established tumors. Now, a study led by researchers at the Ludwig Center at Memorial Sloan Kettering (MSK), MSK, Weill Cornell Medical College in New York and the Icahn School of Medicine at Mount Sinai has modeled and experimentally verified the interplay between the selection of mutations in such genes and their tendency to invite an immune attack on tumor cells. Its findings, reported in the current issue of Nature, reveal a central tradeoff that guides tumor evolution and that might be exploited for both cancer prevention and therapy.
Wireless Implant for Anti-Cancer Photodynamic Therapy
Conn Hastings received a PhD from the Royal College of Surgeons in Ireland for his work in drug delivery, investigating the potential of injectable hydrogels to deliver cells, drugs and nanoparticles in the treatment of cancer and cardiovascular diseases. After achieving his PhD and completing a year of postdoctoral research, Conn pursued a career in academic publishing, before becoming a full-time science writer and editor, combining his experience within the biomedical sciences with his passion for written communication.
Tyler Reddick outduels Chase Elliott at Road America for first NASCAR Cup victory
PLYMOUTH, Wis. (NASCAR) – It was a dogfight between two drivers, pure and simple. It was Tyler Reddick who outdueled pole winner Chase Elliott in the intense mano-a-mano battle in Sunday’s Kwik Trip 250 at Road America. The victory was Reddick’s firs
Where will Robert Dillingham land?
The Kentucky Wildcats could be on the verge of adding a significant piece to their 2023 recruiting class. Tonight at 7 pm ET, No. 1 point guard target Robert Dillingham will make his decision. His finalists include Kentucky, Auburn, Louisville, and U
The Pandemic was Proof that We can Limit Global Warming, Here’s How
Despite academics stressing that reducing planetary heat to 1.5°C is rapidly escaping from human control, researchers understand this would require a massive attempt to accomplish. However, the magnitude of decarbonisation necessary has now been acco
Codemasters breaks down how it made the cars in F1 22 sound like the real thing
Codemasters breaks down how it made the cars in F1 22 sound like the real thing
EA's Codemasters is making F1 2022 audio more realistic with an improved driver modes plus updates that make broadcast and car sounds more authentic, it revealed in
The Never-Ending Psychedelic Trip of Michael Pollan
With his new Netflix doc ‘How to Change Your Mind,’the journalist and psychedelic advocate brings mind-altering — and life-changing — substances to the people
The post The Never-Ending Psychedelic Trip of Michael Pollan first appeared on
Ruling could dampen government efforts to rein in Big Tech
The Supreme Court’s latest climate change ruling could dampen efforts by federal agencies to rein in the tech industry, which went largely unregulated for decades as the government tried to catch up to changes wrought by the internet
India bans some single-use plastic as part of broader plan
India banned some single-use or disposable plastic products Friday as a part of a federal plan to phase out the ubiquitous material in the nation of nearly 1.4 billion people
The Passenger (La Pasajera)
The Passenger (La Pasajera) is a "creature hits the road" horror film that begins with two tourists being brutally murdered by a monstrously evil-looking possessed woman. Directors Raúl Cerezo and Fernando González Gómez offer an uncanny premise and deliver a well-crafted and intentionally disturbing genre story. Screenwriter Luis Sánchez-Polack quickly establishes the characters and their individual
Minions: The Rise of Gru
Honestly, I don't know that I'd be watching the Despicable Me and Minions franchises if I didn't have a kid. Thankfully, there's just enough fun for us adults to get through each installment without going mad. How's that for a backhanded compliment for the latest entry in the franchise, Minions: The Rise of Gru, directed by Kyle Balda, Brad Ableson,
I’ll Never Be Alive Again
After a deadly virus ravaged the world, scientists were able to bring the dead back to life to get a second chance at life in Anisha Savan's sci-fi/horror short, I'll Never Be Alive Again. Anand (Shiv Masand) is a young woman who was brought back to life, now finding herself in a "cured zombie" state. She
Top Tips to Play Roulette Effectively
Roulette is a gambling game with a revolving wheel and a ball that rotates in numbered compartments. The players bet on the numbers where the ball will reside. Many people are of the assumption that Roulettes are easy to battle with and do not require any specific knowledge. But here's the catch. People with wrong
Avian flu is killing thousands of UK birds
Wildlife groups are warning that an outbreak of avian flu could have a potentially devastating impact on Britain’s wild birds, especially globally important seabird populations.
Virgin Orbit rocket launches 7 US defense satellites
A Virgin Orbit rocket carrying seven U.S. Defense Department satellites has been launched from a special Boeing 747 flying off the Southern California coast